Shivantha Siddharth, Au Nicole Ling Shan, Gurrin Lyle, Thornton Jim, Nielsen Jeremy, Mol Ben W
Department of Obstetrics and Gynaecology, Monash University, Clayton, Australia.
Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Parkville, Australia.
BJOG. 2025 Jun;132(7):892-901. doi: 10.1111/1471-0528.18100. Epub 2025 Feb 26.
Potentially untrustworthy medical research is often identified after publication. We evaluated the effectiveness and efficiency of post-publication review of such studies in women's health.
Cohort study.
Potentially untrustworthy papers published in women's health journals.
We wrote to the editors and publishers about potentially untrustworthy papers in women's health and requested an investigation according to the procedure established by the Committee of Publication Ethics (COPE).
Study characteristics, investigation outcome classed as retraction, expression of concern (EoC), correction or no wrongdoing found, and time to decision. We also report the case completion rate per journal and publisher.
Between 7th November 2017 and 30th April 2024, we wrote to editors and publishers of 891 potentially untrustworthy papers published in 206 different journals. At present, 263 (30%) of 891 papers received an outcome, with 227 (86%) labelled as problematic [152 (58%) retracted; 75 (29%) EoC]. For articles with a decision, it took a median time of 38 months for editors and publishers to decide, with 13% of the flagged cases reaching a decision within 12 months.
The current PPR process is inefficient and ineffective in assessing and removing untrustworthy data from the medical literature.
潜在不可信的医学研究往往在发表后才被发现。我们评估了此类女性健康研究发表后审查的有效性和效率。
队列研究。
发表在女性健康期刊上的潜在不可信论文。
我们就女性健康领域潜在不可信的论文写信给编辑和出版商,并要求按照出版伦理委员会(COPE)制定的程序进行调查。
研究特征、调查结果分为撤稿、表达关注(EoC)、更正或未发现不当行为以及做出决定的时间。我们还报告了每个期刊和出版商的案件完成率。
在2017年11月7日至2024年4月30日期间,我们写信给206种不同期刊上发表的891篇潜在不可信论文的编辑和出版商。目前,891篇论文中有263篇(30%)得到了结果,其中227篇(86%)被标记为有问题[152篇(58%)撤稿;75篇(29%)表达关注(EoC)]。对于有决定的文章,编辑和出版商做出决定的中位时间为38个月,13%的标记案例在12个月内做出了决定。
当前的发表后审查流程在评估和清除医学文献中不可信数据方面效率低下且效果不佳。